What does it take to build and scale a successful pharmaceutical venture in an evolving healthcare landscape? Join us for our latest webinar, hosted by Professor Barrie Kellam, Head of the School of Pharmacy, as we bring together Nottingham alumni who have established careers as pharmaceutical and healthcare entrepreneurs.

Pharmacy Entrepreneurial 800x new

Our panel will share insights into the opportunities, challenges and key lessons of pharmaceutical entrepreneurship.

You will learn:

  • How to navigate the journey from concept to commercial and societal impact.
  • How to build and sustain success in a rapidly changing healthcare environment.
  • Practical insights and reflections from the panellists on what they have learned through their careers and how their approaches to entrepreneurship have developed.

Discussion topics will include digital innovation and artificial intelligence, funding and investment, regulatory considerations, talent acquisition and retention, and evolving market dynamics. In this interactive webinar, you’ll have the opportunity to engage with our panel in a Q&A, gaining valuable perspectives from experienced leaders in the sector.

Our panel:

  • - Founder and CEO of CamGene, a biotechnology company developing therapies to reverse hearing loss, which Arpan built from concept into an established venture. He is a biotechnology entrepreneur with over a decade of experience.

  • - Vice-Chancellor of Keele University and a successful entrepreneur and innovator. Kevin founded the regenerative medicine company Locate Bio Ltd and has held leadership positions with national organisations supporting scientific research and innovation.

  • - A footballer turned multi-award winning Pharma Executive, entrepreneur, NED and philanthropist. Claire is founder and CEO of Agility Life Sciences, a multi-award winning formulation development Contract Development and Manufacturing Organisation.

  • - A Royal Society Entrepreneur in Residence, Martin has over 20 years’ experience working in the pharmaceutical industry. Two of his products have been approved worldwide for the treatment of rare diseases of cortisol deficiency.